BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16097572)

  • 1. Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: a review of the literature and implications for practice.
    Seddon BM; Cassoni AM; Galloway MJ; Rees JH; Whelan JS
    Clin Oncol (R Coll Radiol); 2005 Aug; 17(5):385-90. PubMed ID: 16097572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data.
    Bölling T; Dirksen U; Ranft A; Ernst I; Jürgens H; Willich N
    Strahlenther Onkol; 2009 Aug; 185 Suppl 2():21-2. PubMed ID: 19685030
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy and radiotherapy causing radiation myelopathy: what is to blame?
    Walther J; Sivabalasingham S; Plowman PN
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):86. PubMed ID: 16477928
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiotherapy and high-dose chemotherapy in advanced Ewing's tumors.
    Pape H; Laws HJ; Burdach S; van Kaik B; Glag M; Gripp S; Wittkamp M; Jürgens H; Göbel U; Schmitt G
    Strahlenther Onkol; 1999 Oct; 175(10):484-7. PubMed ID: 10554642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours.
    McTiernan A; Driver D; Michelagnoli MP; Kilby AM; Whelan JS
    Ann Oncol; 2006 Aug; 17(8):1301-5. PubMed ID: 16782749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma.
    Drabko K; Raciborska A; Bilska K; Styczynski J; Ussowicz M; Choma M; Wojcik B; Zaucha-Prazmo A; Gorczynska E; Skoczen S; Wozniak W; Chybicka A; Wysocki M; Gozdzik J; Kowalczyk J
    Bone Marrow Transplant; 2012 Dec; 47(12):1530-4. PubMed ID: 22609883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
    Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH; Meyers PA
    J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma.
    Atra A; Whelan JS; Calvagna V; Shankar AG; Ashley S; Shepherd V; Souhami RL; Pinkerton CR
    Bone Marrow Transplant; 1997 Nov; 20(10):843-6. PubMed ID: 9404924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
    Ataergin S; Ozet A; Solchaga L; Turan M; Beyzadeoglu M; Oysul K; Arpaci F; Komurcu S; Surenkok S; Ozturk M
    Med Oncol; 2009; 26(3):276-86. PubMed ID: 18989798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.
    Drabko K; Zawitkowska-Klaczynska J; Wojcik B; Choma M; Zaucha-Prazmo A; Kowalczyk J; Gorczynska E; Toporski J; Kałwak K; Turkiewicz D; Chybicka A
    Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
    Laurence V; Pierga JY; Barthier S; Babinet A; Alapetite C; Palangié T; de Pinieux G; Anract P; Pouillart P
    Am J Clin Oncol; 2005 Jun; 28(3):301-9. PubMed ID: 15923805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification of pulmonary toxicities in the combination of whole lung irradiation and high-dose chemotherapy for Ewing sarcoma patients with lung metastases: a review.
    Scobioala S; Eich HT
    Strahlenther Onkol; 2020 Jun; 196(6):495-504. PubMed ID: 32166453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk adapted chemotherapy for localised Ewing's sarcoma of bone: the French EW93 study.
    Gaspar N; Rey A; Bérard PM; Michon J; Gentet JC; Tabone MD; Roché H; Defachelles AS; Lejars O; Plouvier E; Schmitt C; Bui B; Boutard P; Taque S; Munzer M; Vannier JP; Plantaz D; Entz-Werle N; Oberlin O
    Eur J Cancer; 2012 Jun; 48(9):1376-85. PubMed ID: 22516209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors.
    Hawkins D; Barnett T; Bensinger W; Gooley T; Sanders J
    Med Pediatr Oncol; 2000 May; 34(5):328-37. PubMed ID: 10797354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of Ewing's sarcoma to sequential cyclophosphamide and adriamycin induction therapy.
    Hayes FA; Thompson EI; Hustu HO; Kumar M; Coburn T; Webber B
    J Clin Oncol; 1983 Jan; 1(1):45-51. PubMed ID: 6668483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
    Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
    J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
    Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
    J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation myelopathy after 36 Gy in 12 fractions palliative chest radiotherapy for squamous cell cancer of the lung: case report and review of published studies.
    Harrington C; James M; Wynne C
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):561-3. PubMed ID: 20570499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.